The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; 46 of the 60 sources its claims cite were checked for support.
5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study
Open accessAbstract
Background In DiRECT, a randomised controlled effectiveness trial, weight management intervention after 2 years resulted in mean weight loss of 7·6 kg, with 36% of participants in remission of type 2 diabetes. Of 36 in the intervention group who maintained over 10 kg weight loss at 2 years, 29 (81%) were in remission. Continued low-intensity dietary support was then offered up to 5 years from baseline to intervention participants, aiming to maintain weight loss and gain clinical benefits. This extension study was designed to provide observed outcomes at 5 years. Methods The DiRECT trial took place in primary care practices in the UK. Participants were individuals aged 20–65 years who had less than 6 years' duration of type 2 diabetes, a BMI greater than 27 kg/m 2 , and were not on insulin. The intervention consisted of withdrawal of antidiabetic and antihypertensive drugs, total diet replacement (825–853 kcal per day formula diet for 12–20 weeks), stepped food reintroduction (2–8 weeks), and then structured support for weight-loss maintenance. After sharing the 2-year results with all participants, UK National Health Service data were collected annually until year 5 from remaining intervention participants who received low-intensity dietary support, intervention withdrawals, and the original randomly allocated groups. The primary outcome was remission of type 2 diabetes; having established in the DiRECT trial that sustained weight loss was the dominant driver of remission, this was assumed for the Extension study. The trial is registered with the ISRCTN registry, number 03267836. Findings Between July 25, 2014, and Aug 5, 2016, 149 participants were randomly assigned to the intervention group and 149 were assigned to the control group in the original DiRECT study. After 2 years, all intervention participants still in the trial (101 [68%] of 149) were approached to receive low-intensity support for a further 3 years. 95 (94%) of 101 were able to continue and consented and were allocated to the DiRECT extension group. 54 participants were allocated to the non-extension group, where intervention was withdrawn. At 5 years, DiRECT extension participants (n=85) lost an average of 6·1 kg, with 11 (13%) of 85 in remission. Compared with the non-extension group, DiRECT extension participants had more visits with HbA 1c <48 mmol/mol (<6·5%; 36% vs 17%, p=0·0004), without glucose-lowering medication (62% vs 30%, p<0·0001), and in remission (34% vs 12%, p<0·0001). Original control participants (n=149) had mean weight loss 4·6 kg (n=82), and 5 (5%) of 93 were in remission. Compared with control participants, original intervention participants had more visits with weight more than 5% below baseline (61% vs 29%, p<0·0001), HbA 1c below 48 mmol/mol (29% vs 15%, p=0·0002), without antidiabetic medication (51% vs 16%, p<0·0001), and in remission (27% vs 4%, p<0·0001). Of those in remission at year 2, 26% remained in remission at 5 years. Serious adverse events in the original intervention group (4·8 events per 100 patient-years) were under half those in the control group (10·2 per 100 patient-years, p=0·0080). Interpretation The extended DiRECT intervention was associated with greater aggregated and absolute weight loss, and suggested improved health status over 5 years. Funding Diabetes UK.
Overview
CoChat Summary
TL;DR
In the 5-year extension of DiRECT, continued low-intensity dietary support after 2 years was associated with maintained weight loss and better aggregated glycaemic outcomes than no extension, but remission rates fell substantially by year 5. The authors report observational differences beyond the original randomised period, with weight regain and loss of remission common.
Key findings
- At 5 years, DiRECT extension participants (n=85) had lost a mean of 6·1 kg, and 11 (13%) of 85 were in remission; among those in remission at year 2, 26% remained in remission at 5 years.
- Compared with the non-extension group, extension participants had more follow-up visits with HbA1c <48 mmol/mol (36% vs 17%, p=0·0004), without glucose-lowering medication (62% vs 30%, p<0·0001), and in remission (34% vs 12%, p<0·0001).
- Compared with original control participants, original intervention participants had more visits with weight >5% below baseline (61% vs 29%, p<0·0001), HbA1c <48 mmol/mol (29% vs 15%, p=0·0002), without antidiabetic medication (51% vs 16%, p<0·0001), and in remission (27% vs 4%, p<0·0001).
- Serious adverse events in the original intervention group were 4·8 per 100 patient-years versus 10·2 per 100 patient-years in the control group (p=0·0080).
Methods
- Extension of the UK primary care DiRECT trial: 298 adults aged 20–65 years with type 2 diabetes duration <6 years, BMI >27 kg/m², and not on insulin were originally randomised to intervention or control. After 2 years, 101 remaining intervention participants were offered low-intensity support for 3 further years; 95 consented and formed the DiRECT extension group, while 54 withdrew and formed the non-extension group.
- Routinely collected NHS data were gathered annually to 5 years for original intervention and control participants; outcomes included bodyweight, HbA1c, other biochemistry, medication use, remission (HbA1c <48 mmol/mol without glucose-lowering medication), quality of life, and clinical events.
- Analyses used t-tests, Fisher’s exact tests, bootstrapping with 10,000 replicated datasets, and negative binomial or Poisson regression for event rates; data were reported descriptively without imputation or adjustment for multiple comparisons.
Limitations
- The paper states that the extension group was self-selected by remaining engaged at 2 years; control participants were strongly encouraged to control weight after the randomised trial, so their outcomes do not reflect usual care, and differences beyond 2 years might not reflect intervention.
- The paper states that the original trial was powered to detect 1-year remission differences, not longer-term or other outcomes; years 3–5 were observational, analyses were unadjusted and without imputation, and sparse data bias may affect event estimates.
- The paper notes that many outcomes could not be measured in routine primary care, extension participants were older and probably more health-aware than non-extension participants, and COVID-19 restrictions curtailed planned review appointments and relapse management.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
23 Valid · 10 Not valid · 10 Not checked · 167 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The Diabetes Remission Clinical Trial (DiRECT) found that 46% of people who had type 2 diabetes with less than 6 years' duration and were not on insulin, reach remission at 12 months, defined as HbA1c below 48 mmol/mol (6·5%) without medication, using a structured weight management programme.”
What the sources say
- Supportedcites [2] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Supportedcites [3] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“with 36% of participants in remission of type 2 diabetes.”
What the sources say
- Partly supportedcites [2] sourceExperimental — accuracy not yet measured
The Abstract reports type 2 diabetes remission in 46% of intervention participants at 12 months, not 36% at two years. The Outcomes section specifies 12-month assessment, and the Discussion says longer-term follow-up was still planned; this paper does not establish the claimed two-year figure. (LLM, conf=0.88)
- Partly supportedcites [3] sourceExperimental — accuracy not yet measured
The Abstract (p. 5) reports remission at 24 months in 53 of 149 participants (35.6%) who commenced the intervention. The 36% figure is therefore accurate for the intervention group, but not for DiRECT participants as a whole; remission in the control group was 5 of 149 (3.4%). (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In DiRECT, a randomised controlled effectiveness trial, weight management intervention after 2 years resulted in mean weight loss of 7·6 kg”
What the sources say
- Partly supportedcites [2] sourceExperimental — accuracy not yet measured
The Results report weight loss with the DiRECT intervention, but the reported mean is 10.0 kg at 12 months, not 7.6 kg at two years. The Outcomes section says data were collected at baseline and 12 months; this paper does not provide the claimed two-year result. (LLM, conf=0.88)
- Supportedcites [3] source
The Results (p. 11) report that mean body weight fell by 7.6 kg in the intervention group between baseline and 24 months. This matches the claimed two-year mean weight loss. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Of 36 in the intervention group who maintained over 10 kg weight loss at 2 years, 29 (81%) were in remission.”
What the sources say
- Partly supportedcites [2] sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) reports that remission increased with weight loss, but its results are at 12 months: 31 of 36 participants who lost at least 15 kg were in remission. The Discussion (page unavailable) likewise discusses weight loss maintained at 12 months. Our copy does not support the claimed two-year result of 29 of 36 participants maintaining over 10 kg loss. (LLM, conf=0.87)
- Partly supportedcites [3] sourceExperimental — accuracy not yet measured
The Results (p. 11) report that 36 intervention-group participants maintained at least 10 kg of weight loss at 24 months. They also report 29 remissions among 45 participants with that weight loss, but that figure covers both trial groups, not specifically the 36 in the intervention group. The claimed 29/36 (81%) is therefore not supported by the reported subgroup figures. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Intervention participants were advised regularly to increase physical activity, but they demon strated no net increase”
What the sources say
- Could not verifycites [26] sourceExperimental — accuracy not yet measured
The Methods passages discuss exercise in weight-loss studies, and “Translation to the clinic” discusses recommendations to increase physical activity. Neither reports that intervention participants were regularly advised to increase activity but showed no net increase; searches for that phrase and a paraphrase found no such result in our copy. The available passages have no page numbers. (LLM, conf=0.74)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
96 more claims · 7 with their cited sources checked
Create a free account to see all 210 claims and every source verdict.
- Probably not a substantial claim. 56
- It may state two separate claims as one. 74
- Borderline: one of the tests for a substantial claim is unclear. 1
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“only slightly exceeds the 6.1 % loss sustained in DIRECT [9]”
From 5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study (2024) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, DiRECT intervention arm participants utilizing total diet replacement sustained reductions in hsCRP only through two years [9].”
From 5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study (2024) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Evidence of T2D remission beyond two years is sparse, with examples in bariatric surgery and following the three lifestyle interventions: 1) meal replacements for caloric restriction and physical activity [5,7,8]; 2) short-term total diet replacement with rescue therapy for weight maintenance [9]; and 3) a calorie-restricted Mediterranean diet [10].”
The cited source says what the claim attributes to it.
In the citing paper
“Remission was elicited among 7.3 % at four years by the intensive lifestyle intervention in the Look AHEAD randomized controlled trial utilizing meal replacements and physical activity [6], among 13 % of people treated five years in the DiRECT trial with initial total diet replacement with ongoing rescue therapy [9], and among 5 % at six years in the Mediterranean diet group in the randomized”
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, the average diabetes duration of the full cohort (8 years) and those who sustained remission (5 years) in the present investigation exceeded the 3 year average duration for this diagnosis among those in the DiRECT study [7,9].”
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Summary
“The primary outcome was remission of type 2 diabetes;”
§ Outcomes
“The primary outcomes for the DiRECT extension study were bodyweight, HbA 1c , and other biochemistry.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“We found 45 titles, of which we excluded 29 as not relevant to the present paper”
Reported 45 · recomputed 47
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“although a 1·6 kg weight loss, the observed difference, could be considered a treatment success over 5 years”
§ Statistical analysis
“| Year 5 | 82 | -4·6 (6·1) | 116 | -5·6 (5·8) | -1·1 (-2·8 to 0·6)”
Citations
Cites
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095
Self-citationWeight gain as a risk factor for clinical diabetes mellitus in women
Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064
Long-term persistence of hormonal adaptations to weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105816 · Cited by 1,449
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Self-citationLean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017
Self-citationSparse data bias: a problem hiding in plain sight
Greenland, S., Mansournia, M. A., & Altman, D. G. (2016) · BMJ · doi:10.1136/bmj.i1981 · Cited by 898
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
(2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30162-0 · Cited by 738
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Capristo, E., Chamseddine, G., Bornstein, S. R., & Rubino, F. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32649-0 · Cited by 577
Research works printed but not linked: 2
- Gregg, 2024, Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study, Diabetologia, 67, 459, 10.1007/s00125-023-06048-6 · DOI · Paper page
- Brosnahan, 2021, Brief formula low-energy-diet for relapse management during weight loss maintenance in the Diabetes Remission Clinical Trial (DiRECT), J Hum Nutr Diet, 34, 472, 10.1111/jhn.12839 · DOI · Paper page
Cited by
Lingvay, I., Cohen, R. V., Roux, C. W. L., & Sumithran, P. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01210-8 · Cited by 433
Understanding the cause of type 2 diabetes
Taylor, R. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00157-8 · Cited by 88
Self-citationValabhji, J., Gorton, T., Barron, E., Safazadeh, S., Earnshaw, F., Helm, C., Virr, M., Kernan, J., Crowe, S., Aveyard, P., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00194-3 · Cited by 72
Self-citationBajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s008 · Cited by 126
Diabetes as a risk factor for MASH progression
Gancheva, S., Roden, M., & Castéra, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111846 · Cited by 61
Metadata
- Authors
- Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., Hollingsworth, K. G., Adamson, A. J., Sniehotta, F. F., Mathers, J. C., McIlvenna, Y., Welsh, P., McConnachie, A., McIntosh, A., Sattar, N., & Taylor, R.
- Affiliations
- University of Glasgow (GB)
- Newcastle University (GB)
- Heidelberg University (DE)
- Corresponding author
- Lean, Michael EJ
- ORCID
- Venue
- The Lancet Diabetes & Endocrinology
- Publisher
- Elsevier BV
- Published
- 2024-04
- Volume
- 12
- Issue
- 4
- Pages
- 233-246
- ISSN
- 2213-8587 (ISSN-L)
- OpenAlex
- W4392163265
- Cited by
- 186
- References
- 53
- Citations by year
- 2026: 73 · 2025: 87 · 2024: 26
- FWCI
- 60.84
- Type
- journal article
- Language
- en
- Update notices
- erratum (2024-06-01)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Diabetes & Endocrinology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion, cc-by-sa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Diabetes UK (19/0005976, 13/0004691)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes remission, weight loss maintenance, total diet replacement, long-term follow-up, primary care, antihypertensive drug withdrawal, sustained weight loss, extension study, National Health Service
- MeSH terms
- Diabetes Mellitus, Type 2, Follow-Up Studies, United Kingdom, Humans, Hypoglycemic Agents, State Medicine, Weight Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. https://app.cochat.ai/papers/10.1016/s2213-8587(23)00385-6
- The paper
- Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., Hollingsworth, K. G., Adamson, A. J., Sniehotta, F. F., Mathers, J. C., McIlvenna, Y., Welsh, P., McConnachie, A., McIntosh, A., Sattar, N., & Taylor, R. (2024). 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(23)00385-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.